El-Erian Says He Is 'Disappointed' By What Jerome Powell Did Not Cover In His Jackson Hole Speech

Published : Aug 25, 2025, 08:11 PM IST
https://stocktwits.com/news-articles/markets/equity/el-erian-disappointed-in-jerome-powell-jackson-hole-speech/chssqnfRd1D

Synopsis

The economist said that while he appreciates Powell touching upon risks due to labor market weakness in his speech, he left out what would be the second and third-order effects of the structural changes mentioned during the speech.

Chief economic advisor of Allianz, Mohamed El-Erian, on Monday reportedly expressed his disappointment in Federal Reserve Chair Jerome Powell’s highly anticipated Jackson Hole speech.

In an interview with CNBC, El-Erian said that while he appreciates Powell touching upon risks due to labor market weakness in his speech, he left out what would be the second and third-order effects of the structural changes mentioned during the speech.

“He didn’t give much clarity on what happens after September. And then, he said almost nothing about the policy implications of all the structural changes that he mentioned – in the labor force, in the trading system, in the operation of the domestic economy. 

“I’m glad for what he said, I’m disappointed for what he did not cover,” El-Erian added.

Get updates to this story developing <directly on Stocktwits<.<

For updates and corrections, email newsroom[at]stocktwits[dot]com.<

PREV

Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.

Recommended Stories

Travere Therapeutics Stock Slumps After FDA Extends Drug Review Timeline To April
IBRX Garners Retail Attention On Positive Update In Immunotherapy For Lung Cancer Patients